Hannan Kathy Hopinkah 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Aug 4, 2022
Insider Transaction Report
Form 4
Hannan Kathy Hopinkah
Director
Transactions
- Award
Stock Option
2022-08-02+186,915→ 186,915 totalExercise: $2.14Exp: 2032-08-02→ Class A Common Stock (186,915 underlying) - Award
Stock Option
2022-08-02+84,216→ 84,216 totalExercise: $2.03Exp: 2032-08-02→ Class A Common Stock (84,216 underlying) - Award
Class A Common Stock
2022-08-02+56,986→ 61,986 total
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. The vesting date of the RSUs and additional stock options, and in the case of the additional stock options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
- [F2]In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is a prorated amount based on $200,000.
- [F3]The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
- [F4]In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is $400,000.